Quince Therapeutics
Stock Forecast, Prediction & Price Target

Quince Therapeutics Financial Estimates

Quince Therapeutics Revenue Estimates

Quince Therapeutics EBITDA Estimates

Quince Therapeutics Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$0
 
0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Net Income
 
% change YoY
$-89.32M
 
N/A
$-51.66M
 
42.16%
$-31.38M
 
39.24%
Avg: $-57.34M
Low: $-57.34M
High: $-57.34M
avg. -82.71%
Avg: $-35.00M
Low: $-35.00M
High: $-35.00M
avg. 38.96%
EBITDA
 
% change YoY
$-89.97M
 
N/A
$-50.16M
 
44.24%
$-31.26M
 
37.68%
Avg: $0
Low: $0
High: $0
avg. 100%
Avg: $0
Low: $0
High: $0
avg. 0%
EPS
 
% change YoY
-$3.01
 
N/A
-$1.54
 
48.83%
-$0.84
 
45.45%
Avg: -$1.54
Low: -$1.54
High: -$1.54
avg. -83.33%
Avg: -$0.94
Low: -$0.94
High: -$0.94
avg. 38.96%
Operating Expenses
 
% change YoY
$90.31M
 
N/A
$51.19M
 
-43.32%
$34.62M
 
-32.36%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%

FAQ

What is Quince Therapeutics stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of -21.87% in 2025-2026.

We have gathered data from N/A analysts. Their low estimate is -57.34M, average is -57.34M and high is -57.34M.

What is Quince Therapeutics stock revenue growth forecast?

We have gathered data from N/A analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.

What is Quince Therapeutics stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of -22.18% in 2025-2026.

We have gathered data from N/A analysts. Their low earnings per share estimate is -$1.54, average is -$1.54 and high is $-1.54.